Igor Edouard Fisch
Founder at Selexis SA
Profile
Igor Edouard Fisch is the founder of Selexis SA, which was founded in 2001.
He holds the title of Director at Selexis SA. Currently, Dr. Fisch is a Member-Strategy Council at Venturelab AG.
In the past, he was a Director-Executive Board at Viroblock SA from 2010 to 2011 and a Director at Affitech A from 2011 to 2012.
Dr. Fisch obtained a doctorate degree from the University of Cambridge.
Igor Edouard Fisch active positions
| Companies | Position | Start |
|---|---|---|
Selexis SA
 Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Founder | 2010-01-20 |
Venturelab AG
 Venturelab AG Investment ManagersFinance Venturelab AG (Venturelab) is an independent venture capital firm headquartered in Schliren, Switzerland. The firm was founded by Beat Schillig and Jordi Monserrat in 2001. | Corporate Officer/Principal | - |
Former positions of Igor Edouard Fisch
| Companies | Position | End |
|---|---|---|
Affitech A/S
 Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Director/Board Member | - |
Viroblock SA
 Viroblock SA Miscellaneous Commercial ServicesCommercial Services Viroblock SA develops and commercializes antiviral products. Viroblock technology uses a novel mechanism of action to inactivate enveloped viruses, human and avian such As influenzas, SARS virus and the AIDS virus. The company was founded by Donald F. H. Wallach in 2005 and is headquartered in Irvine, CA. | Director/Board Member | 2009-07-27 |
Training of Igor Edouard Fisch
| University of Cambridge | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Viroblock SA
Viroblock SA Miscellaneous Commercial ServicesCommercial Services Viroblock SA develops and commercializes antiviral products. Viroblock technology uses a novel mechanism of action to inactivate enveloped viruses, human and avian such As influenzas, SARS virus and the AIDS virus. The company was founded by Donald F. H. Wallach in 2005 and is headquartered in Irvine, CA. | Commercial Services |
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Commercial Services |
Affitech A/S
Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Health Technology |
Venturelab AG
Venturelab AG Investment ManagersFinance Venturelab AG (Venturelab) is an independent venture capital firm headquartered in Schliren, Switzerland. The firm was founded by Beat Schillig and Jordi Monserrat in 2001. | Finance |
- Stock Market
- Insiders
- Igor Edouard Fisch
